|
AU668349B2
(en)
|
1991-04-25 |
1996-05-02 |
Chugai Seiyaku Kabushiki Kaisha |
Reconstituted human antibody against human interleukin 6 receptor
|
|
JP3919830B2
(ja)
|
1992-11-28 |
2007-05-30 |
財団法人化学及血清療法研究所 |
抗ネコヘルペスウイルス−１組換え抗体および該抗体をコードする遺伝子断片
|
|
US5820858A
(en)
|
1993-05-28 |
1998-10-13 |
The Scripps Research Institute |
Methods and compositions for inhibiting CD14 mediated cell activation
|
|
EP1972194A1
(en)
|
1996-12-03 |
2008-09-24 |
Amgen Fremont Inc. |
Transgenic mammals having human ig loci including plural vh and vk regions and antibodies produced therefrom
|
|
US6194551B1
(en)
|
1998-04-02 |
2001-02-27 |
Genentech, Inc. |
Polypeptide variants
|
|
SI1270595T1
(sl)
|
2000-03-03 |
2008-12-31 |
Kyowa Hakko Kogyo Kk |
Protitelo proti CCR4 in njegov fragment
|
|
US7084257B2
(en)
*
|
2001-10-05 |
2006-08-01 |
Amgen Inc. |
Fully human antibody Fab fragments with human interferon-gamma neutralizing activity
|
|
US20030138417A1
(en)
|
2001-11-08 |
2003-07-24 |
Kaisheva Elizabet A. |
Stable liquid pharmaceutical formulation of IgG antibodies
|
|
CA2469833C
(en)
|
2001-12-21 |
2008-05-20 |
Idexx Laboratories, Inc. |
Canine immunoglobulin variable domains, caninized antibodies, and methods for making and using them
|
|
RU2490276C2
(ru)
|
2002-01-18 |
2013-08-20 |
Займоджинетикс, Инк. |
Новый лиганд рецептора цитокина zcytor17
|
|
DK1551876T3
(da)
|
2002-10-16 |
2011-06-14 |
Purdue Pharma Lp |
Antistoffer, der binder til celle-associerede ca 125/0722P og fremgangsmåder til anvendelse deraf
|
|
AR049390A1
(es)
|
2004-06-09 |
2006-07-26 |
Wyeth Corp |
Anticuerpos contra la interleuquina-13 humana y usos de los mismos
|
|
EP1671642A1
(en)
|
2004-12-15 |
2006-06-21 |
Universite D'angers |
Compositions comprising (ant)agonists of oncostatin M (OSM), IL-31 and IFN-gamma for modulating keratinocyte migration and functions via a receptor containing OSMRbeta as a subunit, and applications thereof.
|
|
ES2579758T3
(es)
|
2005-01-28 |
2016-08-16 |
Zymogenetics, Inc. |
Preparaciones homogéneas de IL-31
|
|
EP1858924A1
(en)
|
2005-02-14 |
2007-11-28 |
ZymoGenetics, Inc. |
Methods of treating skin disorders using an il-31ra antagonist
|
|
JP4927762B2
(ja)
|
2005-02-14 |
2012-05-09 |
ザイモジェネティクス， インコーポレイテッド |
Ｉｌ−３１アンタゴニストに対するアトピー性皮膚炎の治療応答を予測する方法
|
|
AU2006226192A1
(en)
|
2005-03-19 |
2006-09-28 |
Medical Research Council |
Improvements in or relating to treatment and prevention of viral infections
|
|
US20110123440A1
(en)
|
2005-03-29 |
2011-05-26 |
Genevieve Hansen |
Altered Antibody FC Regions and Uses Thereof
|
|
RU2444528C2
(ru)
|
2005-05-06 |
2012-03-10 |
Займоджинетикс, Инк. |
Моноклональные антитела против il-31 и способы применения
|
|
US8101183B2
(en)
|
2005-05-06 |
2012-01-24 |
Zymogentics, Inc. |
Variable region sequences of IL-31 monoclonal antibodies
|
|
US20130216542A1
(en)
|
2005-05-06 |
2013-08-22 |
Zymogenetics, Inc. |
Variable region sequences of il-31 monoclonal antibodies and methods of use
|
|
CN101198624B
(zh)
|
2005-05-06 |
2012-10-10 |
津莫吉尼蒂克斯公司 |
Il-31单克隆抗体及使用方法
|
|
EP2001906A2
(en)
|
2006-01-10 |
2008-12-17 |
Zymogenetics, Inc. |
Methods of treating pain and inflammation in neuronal tissue using il-31ra and osmrb antagonists
|
|
ZA200900545B
(en)
|
2006-07-18 |
2010-03-31 |
Sanofi Aventis |
Antagonist antibody against EPHA2 for the treatment of cancer
|
|
EP2061811A2
(en)
|
2006-09-01 |
2009-05-27 |
ZymoGenetics, Inc. |
Variable region sequences of il-31 monoclonal antibodies and methods of use
|
|
HUE052220T2
(hu)
|
2006-09-08 |
2021-04-28 |
Abbvie Bahamas Ltd |
Interleukin-13 kötõfehérjék
|
|
ES2501947T3
(es)
|
2006-10-19 |
2014-10-02 |
Csl Limited |
Antagonistas de anticuerpos de alta afinidad del receptor alfa 1 de interleucina
|
|
AU2008204823A1
(en)
|
2007-01-10 |
2008-07-17 |
Zymogenetics, Inc |
Methods of using IL-31 to treat airway hyper-responsiveness and asthma
|
|
JOP20080381B1
(ar)
|
2007-08-23 |
2023-03-28 |
Amgen Inc |
بروتينات مرتبطة بمولدات مضادات تتفاعل مع بروبروتين كونفيرتاز سيتيليزين ككسين من النوع 9 (pcsk9)
|
|
SI2796466T1
(en)
|
2007-12-07 |
2018-01-31 |
Zymogenetics, Inc. |
Molecules of Humanized Specifics Specifiable for IL-31
|
|
CN101939334B
(zh)
|
2007-12-17 |
2015-01-14 |
医疗技术研究局 |
C型肝炎病毒抗体
|
|
TW201920257A
(zh)
|
2008-04-11 |
2019-06-01 |
日商中外製藥股份有限公司 |
重複結合複數個抗原的抗原結合分子
|
|
RS53382B
(sr)
|
2008-08-20 |
2014-10-31 |
Zoetis Llc |
Jedinjenja pirol [2,3-d]pirimidina
|
|
EP2331579B1
(en)
|
2008-09-04 |
2017-07-05 |
Vet Therapeutics, Inc. |
Monoclonal antibodies
|
|
DK3290052T3
(da)
|
2008-11-07 |
2020-02-03 |
Galaxy Biotech Llc |
Monoklonale antistoffer mod fibroblastvækstfaktorreceptor 2
|
|
US20110287454A1
(en)
|
2008-11-25 |
2011-11-24 |
Cornell University |
Methods for monoclonal antibody production
|
|
WO2011065935A1
(en)
|
2009-11-24 |
2011-06-03 |
Cornell University |
Methods for monoclonal antibody production
|
|
US20110165063A1
(en)
|
2009-01-29 |
2011-07-07 |
Abbott Laboratories |
Il-1 binding proteins
|
|
EP2424893A2
(en)
|
2009-06-22 |
2012-03-07 |
Peptcell Limited |
Pharmaceutical agent
|
|
AR078651A1
(es)
|
2009-10-15 |
2011-11-23 |
Abbott Lab |
Inmunoglobulinas con dominio variable dual y usos de las mismas
|
|
JO3244B1
(ar)
|
2009-10-26 |
2018-03-08 |
Amgen Inc |
بروتينات ربط مستضادات il – 23 البشرية
|
|
CN105777907B
(zh)
|
2010-02-24 |
2020-03-17 |
伊缪诺金公司 |
叶酸受体1抗体与免疫缀合物以及其用途
|
|
TWI500427B
(zh)
|
2010-05-14 |
2015-09-21 |
Abbvie Inc |
Ｉｌ－１結合蛋白
|
|
TWI560199B
(en)
|
2010-08-31 |
2016-12-01 |
Sanofi Sa |
Peptide or peptide complex binding to α2 integrin and methods and uses involving the same
|
|
US9255925B2
(en)
|
2010-10-20 |
2016-02-09 |
Medical Diagnostic Laboratories, Llc |
ELISA detection of urine DEK to predict and diagnose bladder cancer in humans
|
|
CN105859889B
(zh)
|
2010-11-17 |
2020-01-07 |
中外制药株式会社 |
具有代替凝血因子viii的功能的功能的多特异性抗原结合分子
|
|
AR084210A1
(es)
|
2010-12-08 |
2013-05-02 |
Abbott Lab |
PROTEINAS DE UNION AL TNF-a
|
|
WO2012088094A2
(en)
|
2010-12-21 |
2012-06-28 |
Abbott Laboratories |
Il-1 binding proteins
|
|
EP2703486B1
(en)
|
2011-04-25 |
2018-03-07 |
Daiichi Sankyo Company, Limited |
Anti-b7-h3 antibody
|
|
AR086250A1
(es)
|
2011-05-05 |
2013-11-27 |
Hoffmann La Roche |
Polipeptido de fusion presentador de una secuencia de aminoacidos y utilizacion del mismo
|
|
AU2012252152B2
(en)
*
|
2011-05-06 |
2016-07-07 |
Zoetis Services Llc |
Anti-nerve growth factor antibodies and methods of preparing and using the same
|
|
US9127065B2
(en)
|
2011-05-19 |
2015-09-08 |
Institut National De La Sante Et De La Recherche Medicale (Inserm) |
Anti-human HER3 antibodies and uses thereof
|
|
US8790651B2
(en)
|
2011-07-21 |
2014-07-29 |
Zoetis Llc |
Interleukin-31 monoclonal antibody
|
|
KR20130036993A
(ko)
|
2011-10-05 |
2013-04-15 |
삼성전자주식회사 |
ｃ-Ｍｅｔ의 ＳＥＭＡ 도메인 내의 에피토프에 특이적으로 결합하는 항체
|
|
HK1201281A1
(en)
*
|
2011-10-13 |
2015-08-28 |
Nexvet Australia Pty Ltd |
Canine/feline cd20 binding epitope and compositions for binding thereto
|
|
WO2014052693A2
(en)
*
|
2012-09-29 |
2014-04-03 |
The Trustees Of The University Of Pennsylvania |
Veterinary composition and methods for non-surgical neutering and castration
|
|
JO3532B1
(ar)
|
2013-03-13 |
2020-07-05 |
Regeneron Pharma |
الأجسام المضادة لمضاد انترلوكين-33 واستعمالاتها
|
|
CN113788897A
(zh)
|
2013-03-15 |
2021-12-14 |
拜尔健康护理有限责任公司 |
改善药代动力学的具有跨pH范围差异结合的抗TFPI抗体变体
|
|
JP6404314B2
(ja)
|
2013-03-15 |
2018-10-10 |
リジェネロン・ファーマシューティカルズ・インコーポレイテッドＲｅｇｅｎｅｒｏｎ Ｐｈａｒｍａｃｅｕｔｉｃａｌｓ， Ｉｎｃ． |
Ｉｌ−３３拮抗薬とその使用法
|
|
KR20240122922A
(ko)
|
2013-03-27 |
2024-08-13 |
세다르스-신나이 메디칼 센터 |
Tl1a 기능 및 관련된 신호전달 경로의 저해에 의한 섬유증 및 염증의 완화 및 반전
|
|
US9499621B2
(en)
*
|
2013-04-08 |
2016-11-22 |
Cytodyn, Inc. |
Felinized antibodies and methods of treating retroviral infections in felines
|
|
CA2903359A1
(en)
|
2013-05-27 |
2014-12-04 |
Fraunhofer-Gesellschaft Zur Foerderung Der Angewandten Forschung E.V. |
Targeted modulation of macrophages
|
|
HUE056580T2
(hu)
|
2013-05-30 |
2022-02-28 |
Kiniksa Pharmaceuticals Ltd |
Onkosztatin-M-receptor antigénjét kötõ fehérjék
|
|
TW201537175A
(zh)
|
2013-06-28 |
2015-10-01 |
Chugai Pharmaceutical Co Ltd |
預測罹患具皮膚搔癢之疾病的患者對ｉｌ－３１拮抗劑之治療的反應之方法
|
|
WO2015002985A2
(en)
|
2013-07-01 |
2015-01-08 |
University Of Maryland |
Fc coupled compositions and methods of their use
|
|
PL3044323T3
(pl)
*
|
2013-09-13 |
2022-06-27 |
F.Hoffmann-La Roche Ag |
Sposoby wykrywania i ilościowego oznaczania białka komórki gospodarza w liniach komórkowych
|
|
WO2015042596A1
(en)
|
2013-09-23 |
2015-03-26 |
Kindred Biosciences, Inc |
Treatment of atopic dermatitis in non-human animals
|
|
US20160297892A1
(en)
|
2013-11-07 |
2016-10-13 |
Novo Nordisk A/S |
Novel Methods and Antibodies for Treating Coagulapathy
|
|
WO2015086830A1
(en)
|
2013-12-13 |
2015-06-18 |
Delenex Therapeutics Ag |
Skin penetrating polypeptides
|
|
CN103965357B
(zh)
*
|
2013-12-31 |
2016-08-17 |
嘉和生物药业有限公司 |
一种抗人rankl抗体
|
|
CA2955947A1
(en)
|
2014-07-25 |
2016-01-28 |
Cytomx Therapeutics, Inc. |
Anti-cd3 antibodies, activatable anti-cd3 antibodies, multispecific anti-cd3 antibodies, multispecific activatable anti-cd3 antibodies, and methods of using the same
|
|
CN104403004B
(zh)
|
2014-11-24 |
2017-10-13 |
苏州丁孚靶点生物技术有限公司 |
抗体‑干扰素异二聚体的制备和用途
|
|
WO2016119023A1
(en)
|
2015-01-29 |
2016-08-04 |
Nexvet Australia Pty Ltd |
Therapeutic and diagnostic agents
|
|
FI3284480T3
(fi)
*
|
2015-04-14 |
2025-09-11 |
Chugai Pharmaceutical Co Ltd |
IL-31-antagonistia vaikuttavana ainesosana sisältävä farmaseuttinen koostumus atooppisen ihottuman ehkäisemiseksi ja/tai hoitamiseksi
|
|
CN116726190A
(zh)
|
2015-06-20 |
2023-09-12 |
杭州多禧生物科技有限公司 |
澳瑞他汀类似物及其与细胞结合分子的共轭偶联物
|
|
WO2017025698A1
(en)
|
2015-08-11 |
2017-02-16 |
Queen Mary University Of London |
Bispecific, cleavable antibodies
|
|
TW201729810A
(zh)
|
2015-10-26 |
2017-09-01 |
札爾科製藥公司 |
嘧啶組成物、其超純組成物及鹽類、製造彼之方法、及使用彼於治療組織胺h4受體(h 4 )仲介之疾病與病情之方法
|
|
PE20190115A1
(es)
*
|
2016-04-15 |
2019-01-16 |
Immunext Inc |
Anticuerpos vista antihumanos y su uso
|
|
MX2018012803A
(es)
|
2016-04-20 |
2019-06-24 |
Hangzhou Dac Biotech Co Ltd |
Derivados de las toxinas de amanita y su conjugacion a una molecula de union celular.
|
|
WO2017192589A1
(en)
*
|
2016-05-02 |
2017-11-09 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Neutralizing antibodies to influenza ha and their use and identification
|
|
EP3526246A1
(en)
|
2016-10-17 |
2019-08-21 |
Vetoquinol SA |
Modified antibody constant region
|
|
KR20220147719A
(ko)
|
2016-11-14 |
2022-11-03 |
항저우 디에이씨 바이오테크 씨오, 엘티디 |
결합 링커, 그러한 결합 링커를 함유하는 세포 결합 분자-약물 결합체, 링커를 갖는 그러한 결합체의 제조 및 사용
|
|
TWI784988B
(zh)
|
2016-12-01 |
2022-12-01 |
美商再生元醫藥公司 |
治療發炎症狀的方法
|
|
WO2018156367A1
(en)
|
2017-02-24 |
2018-08-30 |
Kindred Biosciences, Inc. |
Anti-il31 antibodies for veterinary use
|
|
US10093731B2
(en)
|
2017-02-24 |
2018-10-09 |
Kindred Biosciences, Inc. |
Anti-IL31 antibodies for veterinary use
|
|
KR20210125094A
(ko)
|
2017-04-06 |
2021-10-15 |
항저우 디에이씨 바이오테크 씨오, 엘티디 |
비스-링키지를 사용한 세포독성 약물의 접합
|
|
MY200973A
(en)
|
2017-04-11 |
2024-01-26 |
Inhibrx Inc |
Multispecific Polypeptide Constructs Having Constrained Cd3 Binding And Methods Of Using The Same
|
|
JP7657548B2
(ja)
|
2017-04-21 |
2025-04-07 |
エランコ・ユーエス・インコーポレイテッド |
獣医学的使用のためのｉｌ４／ｉｌ１３受容体分子
|
|
EP3483180A1
(en)
|
2017-11-14 |
2019-05-15 |
Affilogic |
Multi specific molecules
|
|
US20210079054A1
(en)
|
2017-12-11 |
2021-03-18 |
Ubi Us Holdings, Llc. |
Peptide immunogens of il-31 and formulations thereof for the treatment and/or prevention of atopic dermatitis
|
|
JP7262817B2
(ja)
|
2017-12-31 |
2023-04-24 |
ハンジョウ ディーエーシー バイオテック シーオー．，エルティディ． |
分岐連結体を備えたチューブリシン類縁体の共役体
|
|
JP7449234B2
(ja)
|
2018-03-16 |
2024-03-13 |
ゾエティス・サービシーズ・エルエルシー |
獣医学使用のためのインターロイキン３１モノクローナル抗体
|
|
WO2019183449A1
(en)
|
2018-03-23 |
2019-09-26 |
North Carolina State University |
Methods and compositions for allergic disorders
|
|
TW202010757A
(zh)
|
2018-04-11 |
2020-03-16 |
美商英伊布里克斯公司 |
具有經受限cd3結合的多重特異性多肽構築體以及相關方法及用途
|
|
MX2020014083A
(es)
|
2018-07-05 |
2021-04-12 |
Hangzhou Dac Biotech Co Ltd |
Un derivado de dímero de pirrolobenzodiazepina (pbd) reticulado y sus conjugados.
|
|
JP2022500037A
(ja)
*
|
2018-09-14 |
2022-01-04 |
キンドレッド バイオサイエンシズ インコーポレイテッド |
獣医学的使用のための抗ｉｌ４受容体抗体
|
|
US20230010108A1
(en)
|
2018-10-12 |
2023-01-12 |
Hangzhou Dac Biotech Co., Ltd. |
A conjugation linker containing 2,3-diaminosuccinyl group
|
|
EP3866842A4
(en)
|
2018-10-18 |
2022-07-13 |
Kindred Biosciences, Inc. |
FC VARIANTS WITH MODIFIED BINDING TO THE NEONATAL FC RECEPTOR (FCRN) FOR VETERINARY USE
|
|
EP3870601A4
(en)
|
2018-10-25 |
2022-07-13 |
Kindred Biosciences, Inc. |
IL4/IL13 RECEPTOR MOLECULE FOR USE IN VETERINARY MEDICINE
|
|
WO2020092015A1
(en)
|
2018-11-02 |
2020-05-07 |
University Of Rochester |
Therapeutic mitigation of epithelial infection
|
|
WO2020139984A1
(en)
|
2018-12-27 |
2020-07-02 |
Kindred Biosciences, Inc. |
Igg fc variants for veterinary use
|
|
CN120005022A
(zh)
|
2019-01-03 |
2025-05-16 |
因外泰克斯公司 |
用于增加治疗剂在犬中的半衰期的组合物及使用方法
|
|
CA3128264A1
(en)
|
2019-01-31 |
2020-08-06 |
Hangzhou Dac Biotech Co., Ltd |
A conjugate of an amanita toxin with branched linkers
|
|
KR20210143246A
(ko)
|
2019-03-21 |
2021-11-26 |
리제너론 파아마슈티컬스, 인크. |
알레르기 치료용 il-4/il-13 경로 억제제 및 형질 세포 절제의 병용
|
|
CN112203642B
(zh)
|
2019-03-25 |
2025-03-07 |
阿特根公司 |
用于皮下注射的包含人透明质酸酶ph20变体和药物的药物组合物
|
|
CA3144784A1
(en)
|
2019-06-24 |
2020-12-30 |
Hangzhou Dac Biotech Co., Ltd |
A conjugate of a cytotoxic agent to a cell binding molecule with branched linkers
|
|
JP2022544442A
(ja)
|
2019-06-24 |
2022-10-19 |
ハンジョウ ディーエーシー バイオテック シーオー．，エルティディ． |
チューブリシン類縁体と細胞結合分子との共役体の製剤
|
|
JP7671275B2
(ja)
|
2019-08-29 |
2025-05-01 |
エランコ・ユーエス・インコーポレイテッド |
動物用の抗ｉｌ３１抗体
|
|
EP4047019A4
(en)
|
2019-12-13 |
2023-11-15 |
Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. |
Anti-tslp antibody and uses thereof
|
|
WO2021123092A1
(en)
|
2019-12-20 |
2021-06-24 |
Intervet International B.V. |
Bispecific caninized antibodies for treating atopic dermatitis
|
|
CN115135669B
(zh)
|
2020-02-19 |
2026-05-19 |
硕腾服务有限责任公司 |
修饰的Fc区
|
|
US20240067738A1
(en)
|
2020-03-18 |
2024-02-29 |
Elanco Us Inc. |
Anti-il4 receptor antibodies for veterinary use
|
|
IL297287A
(en)
|
2020-04-17 |
2022-12-01 |
Zoetis Services Llc |
Canine antibody variants
|
|
MX2022013149A
(es)
|
2020-04-22 |
2023-02-09 |
Kindred Biosciences Inc |
Moléculas receptoras de interleucina 4/interleucina 13 para uso veterinario.
|
|
CA3173864A1
(en)
|
2020-04-22 |
2021-10-28 |
Shyr Jiann Li |
Long-acting anti-il31 antibodies for veterinary use
|
|
PH12022500032A1
(en)
|
2020-06-19 |
2024-02-26 |
Hangzhou Dac Biotech Co Ltd |
Conjugates of a cell-binding molecule with camptothecin analogs
|
|
CN116096741B
(zh)
|
2020-07-10 |
2024-10-18 |
因外泰克斯公司 |
用于延长治疗剂在猫科动物中的半衰期的组合物和使用方法
|
|
GB202012331D0
(en)
|
2020-08-07 |
2020-09-23 |
Petmedix Ltd |
Therapeutic antibodies
|
|
CA3189847A1
(en)
|
2020-09-01 |
2022-03-10 |
Naoki Fukazawa |
Pharmaceutical composition for prevention and/or treatment of dialysis pruritus containing il-31 antagonist as active ingredient
|